Your browser doesn't support javascript.
loading
C-reactive Protein Levels and Cardiovascular Outcomes After Febuxostat Treatment in Patients with Asymptomatic Hyperuricemia: Post-hoc Analysis of a Randomized Controlled Study.
Kojima, Sunao; Uchiyama, Kazuaki; Yokota, Naoto; Tokutake, Eiichi; Wakasa, Yutaka; Hiramitsu, Shinya; Waki, Masako; Jinnouchi, Hideaki; Kakuda, Hirokazu; Hayashi, Takahiro; Kawai, Naoki; Sugawara, Masahiro; Mori, Hisao; Tsujita, Kenichi; Matsui, Kunihiko; Hisatome, Ichiro; Ohya, Yusuke; Kimura, Kazuo; Saito, Yoshihiko; Ogawa, Hisao.
Afiliação
  • Kojima S; Department of Internal Medicine, Sakurajyuji Yatsushiro Rehabilitation Hospital, 2-4-33 Honmachi, Yatsushiro, 866-0861, Japan. kojimas@kumamoto-u.ac.jp.
  • Uchiyama K; Uchiyama Clinic, 1161-1 Shita-machi, Yoshikawa-ku, Joetsu, 949-3443, Japan.
  • Yokota N; Yokota Naika, 642-1 Komuta, Miyazaki, Hanagashima-cho, 880-0036, Japan.
  • Tokutake E; Tokutake Iin, 2-28-1 Asahi, Kawaguchi, 332-0001, Japan.
  • Wakasa Y; Wakasa Medical Clinic, 3-16-25 Sainen, Kanazawa, 920-0024, Japan.
  • Hiramitsu S; Hiramitsu Heart Clinic, 2-35 Shiroshita-cho, Minami-ku, Nagoya, 457-0047, Japan.
  • Waki M; Shizuoka City Shizuoka Hospital, 10-93 Ote-machi, Shizuoka, Aoi-ku, 420-8630, Japan.
  • Jinnouchi H; Jinnouchi Hospital Diabetes Care Center, 6-2-3 Kuhonji, Kumamoto, Chuo-ku, 862-0976, Japan.
  • Kakuda H; Kakuda Iin, Na 15-1, Takamatsu, Kahoku, 929-1215, Japan.
  • Hayashi T; Hayashi Medical Clinic, 5-22 Nakamozu-cho, Sakai, Kita-ku, 591-8023, Japan.
  • Kawai N; Kawai Naika Clinic, 4-32 Kanazono-cho, Gifu, 500-8113, Japan.
  • Sugawara M; Sugawara Clinic, 3-9-16 Shakujii-machi, Nerima-ku, 177-0041, Japan.
  • Mori H; Fuji Health Promotion Center, 392-5 Yunoki, Fuji, 416-0908, Japan.
  • Tsujita K; Department of Cardiovascular Medicine, Kumamoto University, 1-1-1 Honjo, Kumamoto, Chuo-ku, 860-8556, Japan.
  • Matsui K; Department of Family, Community, and General Medicine, Kumamoto University Hospital, 1-1-1 Honjo, Kumamoto, Chuo-ku, 860-8556, Japan.
  • Hisatome I; Institute of Regenerative Medicine and Biofunction, Tottori University Graduate School of Medical Science, 86 Nishi-machi, Yonago, 683-8503, Japan.
  • Ohya Y; Department of Cardiovascular Medicine, Nephrology and Neurology, University of the Ryukyus School of Medicine 207 Uehara, Okinawa, Nishihara-cho, 903-0215, Japan.
  • Kimura K; Division of Cardiology, Yokohama City University Medical Center, 4-57 Urafune-cho, Yokohama, Minami-ku, 232-0024, Japan.
  • Saito Y; Department of Cardiovascular Medicine, Nara Medical University, 840 Shijyo-cho, Kashihara, 634-8522, Japan.
  • Ogawa H; Kumamoto University, 2-39-1 Kurokami, Kumamoto, Chuo-ku, 860-8555, Japan.
Cardiovasc Drugs Ther ; 37(5): 965-974, 2023 10.
Article em En | MEDLINE | ID: mdl-35648242
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hiperuricemia / Aterosclerose Tipo de estudo: Clinical_trials Limite: Female / Humans / Male Idioma: En Revista: Cardiovasc Drugs Ther Assunto da revista: ANGIOLOGIA / CARDIOLOGIA / TERAPIA POR MEDICAMENTOS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Japão
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hiperuricemia / Aterosclerose Tipo de estudo: Clinical_trials Limite: Female / Humans / Male Idioma: En Revista: Cardiovasc Drugs Ther Assunto da revista: ANGIOLOGIA / CARDIOLOGIA / TERAPIA POR MEDICAMENTOS Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Japão